科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2014/02/04 | 1,590 | 1,593 | 1,558 | 1,559 | -71 | -4.4% | 462,000 |
| 2014/02/03 | 1,641 | 1,659 | 1,623 | 1,630 | -12 | -0.7% | 294,000 |
| 2014/01/31 | 1,647 | 1,667 | 1,627 | 1,642 | -11 | -0.7% | 422,000 |
| 2014/01/30 | 1,750 | 1,750 | 1,647 | 1,653 | -23 | -1.4% | 527,000 |
| 2014/01/29 | 1,597 | 1,678 | 1,597 | 1,676 | +82 | +5.1% | 384,000 |
| 2014/01/28 | 1,602 | 1,616 | 1,593 | 1,594 | -10 | -0.6% | 279,000 |
| 2014/01/27 | 1,612 | 1,638 | 1,600 | 1,604 | -23 | -1.4% | 199,000 |
| 2014/01/24 | 1,641 | 1,653 | 1,622 | 1,627 | -38 | -2.3% | 370,000 |
| 2014/01/23 | 1,683 | 1,687 | 1,665 | 1,665 | -8 | -0.5% | 231,000 |
| 2014/01/22 | 1,672 | 1,676 | 1,655 | 1,673 | +1 | +0.1% | 238,000 |
| 2014/01/21 | 1,679 | 1,688 | 1,668 | 1,672 | -7 | -0.4% | 179,000 |
| 2014/01/20 | 1,688 | 1,688 | 1,669 | 1,679 | -8 | -0.5% | 329,000 |
| 2014/01/17 | 1,678 | 1,690 | 1,667 | 1,687 | +29 | +1.7% | 381,000 |
| 2014/01/16 | 1,622 | 1,682 | 1,622 | 1,658 | +38 | +2.3% | 586,000 |
| 2014/01/15 | 1,584 | 1,622 | 1,576 | 1,620 | +40 | +2.5% | 372,000 |
| 2014/01/14 | 1,583 | 1,587 | 1,543 | 1,580 | -10 | -0.6% | 245,000 |
| 2014/01/10 | 1,583 | 1,590 | 1,573 | 1,590 | +7 | +0.4% | 194,000 |
| 2014/01/09 | 1,587 | 1,589 | 1,575 | 1,583 | -5 | -0.3% | 200,000 |
| 2014/01/08 | 1,566 | 1,588 | 1,566 | 1,588 | +23 | +1.5% | 162,000 |
| 2014/01/07 | 1,588 | 1,588 | 1,562 | 1,565 | ±0 | ±0% | 191,000 |
| 2014/01/06 | 1,583 | 1,588 | 1,561 | 1,565 | -15 | -0.9% | 313,000 |
| 2013/12/30 | 1,565 | 1,584 | 1,556 | 1,580 | +24 | +1.5% | 177,000 |
| 2013/12/27 | 1,530 | 1,556 | 1,518 | 1,556 | +24 | +1.6% | 297,000 |
| 2013/12/26 | 1,510 | 1,534 | 1,499 | 1,532 | +42 | +2.8% | 274,000 |
| 2013/12/25 | 1,487 | 1,494 | 1,480 | 1,490 | -5 | -0.3% | 539,000 |
| 2013/12/24 | 1,513 | 1,515 | 1,490 | 1,495 | -18 | -1.2% | 365,000 |
| 2013/12/20 | 1,520 | 1,524 | 1,510 | 1,513 | -7 | -0.5% | 316,000 |
| 2013/12/19 | 1,510 | 1,521 | 1,506 | 1,520 | +13 | +0.9% | 409,000 |
| 2013/12/18 | 1,498 | 1,516 | 1,498 | 1,507 | -9 | -0.6% | 337,000 |
| 2013/12/17 | 1,513 | 1,516 | 1,502 | 1,516 | +10 | +0.7% | 270,000 |
| 2013/12/16 | 1,518 | 1,522 | 1,498 | 1,506 | -21 | -1.4% | 301,000 |
| 2013/12/13 | 1,535 | 1,539 | 1,525 | 1,527 | -4 | -0.3% | 486,000 |
| 2013/12/12 | 1,540 | 1,542 | 1,525 | 1,531 | -8 | -0.5% | 186,000 |
| 2013/12/11 | 1,545 | 1,549 | 1,530 | 1,539 | -8 | -0.5% | 226,000 |
| 2013/12/10 | 1,546 | 1,550 | 1,540 | 1,547 | +3 | +0.2% | 204,000 |
| 2013/12/09 | 1,543 | 1,550 | 1,540 | 1,544 | +9 | +0.6% | 279,000 |
| 2013/12/06 | 1,519 | 1,542 | 1,515 | 1,535 | +22 | +1.5% | 462,000 |
| 2013/12/05 | 1,524 | 1,531 | 1,513 | 1,513 | -11 | -0.7% | 316,000 |
| 2013/12/04 | 1,536 | 1,543 | 1,518 | 1,524 | -12 | -0.8% | 398,000 |
| 2013/12/03 | 1,550 | 1,557 | 1,534 | 1,536 | -11 | -0.7% | 322,000 |
| 2013/12/02 | 1,550 | 1,562 | 1,543 | 1,547 | -4 | -0.3% | 256,000 |
| 2013/11/29 | 1,553 | 1,560 | 1,540 | 1,551 | -2 | -0.1% | 207,000 |
| 2013/11/28 | 1,561 | 1,571 | 1,549 | 1,553 | -11 | -0.7% | 145,000 |
| 2013/11/27 | 1,580 | 1,581 | 1,531 | 1,564 | -15 | -0.9% | 197,000 |
| 2013/11/26 | 1,588 | 1,588 | 1,578 | 1,579 | -13 | -0.8% | 163,000 |
| 2013/11/25 | 1,595 | 1,596 | 1,582 | 1,592 | +6 | +0.4% | 167,000 |
| 2013/11/22 | 1,579 | 1,589 | 1,573 | 1,586 | +13 | +0.8% | 282,000 |
| 2013/11/21 | 1,579 | 1,583 | 1,566 | 1,573 | -2 | -0.1% | 202,000 |
| 2013/11/20 | 1,572 | 1,580 | 1,569 | 1,575 | +3 | +0.2% | 301,000 |
| 2013/11/19 | 1,567 | 1,575 | 1,563 | 1,572 | +4 | +0.3% | 150,000 |
2751～
2800
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 400,000円 | +30.5% | +111.0% | 4.75% | 11.27倍 | 0.98倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| サワイＧＨＤ | 199,600円 | +4.0% | +25.4% | 2.66% | 8.73倍 | 1.15倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 397,500円 | +3.6% | +6.1% | 3.02% | 13.83倍 | 0.81倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| サンバイオ | 229,200円 | - | - | 0.00% | - | 106.16倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
